000 01573 a2200445 4500
005 20250514184729.0
264 0 _c20040614
008 200406s 0 0 eng d
022 _a0020-7136
024 7 _a10.1002/ijc.11649
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKleiman, Anna
245 0 0 _aHERV-K(HML-2) GAG/ENV antibodies as indicator for therapy effect in patients with germ cell tumors.
_h[electronic resource]
260 _bInternational journal of cancer
_cJun 2004
300 _a459-61 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntibodies
_xchemistry
650 0 4 _aAntibodies, Viral
650 0 4 _aBlotting, Western
650 0 4 _aDisease Progression
650 0 4 _aEndogenous Retroviruses
_xgenetics
650 0 4 _aGene Products, env
_ximmunology
650 0 4 _aGene Products, gag
_ximmunology
650 0 4 _aGenetic Therapy
_xmethods
650 0 4 _aHumans
650 0 4 _aNeoplasm Metastasis
650 0 4 _aNeoplasms, Germ Cell and Embryonal
_xgenetics
650 0 4 _aProviruses
_xgenetics
650 0 4 _aTime Factors
650 0 4 _aViral Proteins
_xgenetics
700 1 _aSenyuta, Natalia
700 1 _aTryakin, Alexey
700 1 _aSauter, Marlies
700 1 _aKarseladze, Apollon
700 1 _aTjulandin, Sergei
700 1 _aGurtsevitch, Vladimir
700 1 _aMueller-Lantzsch, Nikolaus
773 0 _tInternational journal of cancer
_gvol. 110
_gno. 3
_gp. 459-61
856 4 0 _uhttps://doi.org/10.1002/ijc.11649
_zAvailable from publisher's website
999 _c14807988
_d14807988